Abcellera Biologics Inc (ABCL) — Financial Flexibility Index
Abcellera Biologics Inc (ABCL) has a Financial Flexibility Index of -0.08x as of June 2026. Free cash flow of $-31.73 Million (operating CF $-33.86 Million minus capex $2.13 Million) represents 0% of total liabilities ($411.56 Million). Check ABCL total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Abcellera Biologics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Abcellera Biologics Inc across 8 annual periods. For the full cash flow conversion analysis, see Abcellera Biologics Inc cash flow conversion.
Annual Financial Flexibility Index for Abcellera Biologics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Abcellera Biologics Inc. Explore how well can Abcellera Biologics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-88.52 Million | $-131.29 Million | $390.05 Million | ▼ -129.1% |
| 2024 | -0.10x | $-30.16 Million | $-108.56 Million | $304.47 Million | ▼ -198.9% |
| 2023 | 0.10x | $33.63 Million | $-43.88 Million | $335.78 Million | ▼ -91.2% |
| 2022 | 1.14x | $350.02 Million | $277.36 Million | $307.63 Million | ▲ +9.9% |
| 2021 | 1.03x | $303.04 Million | $244.58 Million | $292.84 Million | ▲ +384.8% |
| 2020 | 0.21x | $37.36 Million | $22.69 Million | $175.03 Million | ▼ -57.8% |
| 2019 | 0.51x | $6.69 Million | $2.69 Million | $13.24 Million | ▼ -43.7% |
| 2018 | 0.90x | $8.87 Million | $3.56 Million | $9.88 Million | — |